Cargando…
The mTOR inhibitor Rapamycin protects from premature cellular senescence early after experimental kidney transplantation
Interstitial fibrosis and tubular atrophy, a major cause of kidney allograft dysfunction, has been linked to premature cellular senescence. The mTOR inhibitor Rapamycin protects from senescence in experimental models, but its antiproliferative properties have raised concern early after transplantati...
Autores principales: | Hoff, Uwe, Markmann, Denise, Thurn-Valassina, Daniela, Nieminen-Kelhä, Melina, Erlangga, Zulrahman, Schmitz, Jessica, Bräsen, Jan Hinrich, Budde, Klemens, Melk, Anette, Hegner, Björn |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9022825/ https://www.ncbi.nlm.nih.gov/pubmed/35446876 http://dx.doi.org/10.1371/journal.pone.0266319 |
Ejemplares similares
-
Low-dose rapamycin does not impair vascular integrity and tubular regeneration after kidney transplantation in rats
por: Hoff, Uwe, et al.
Publicado: (2021) -
Mechanistic Target of Rapamycin (mTOR) in the Cancer Setting
por: Murray, James T., et al.
Publicado: (2018) -
Unbiased evaluation of rapamycin's specificity as an mTOR inhibitor
por: Artoni, Filippo, et al.
Publicado: (2023) -
Premature recruitment of oocyte pool and increased mTOR activity in Fmr1 knockout mice and reversal of phenotype with rapamycin
por: Mok-Lin, E., et al.
Publicado: (2018) -
Effects of the mTOR inhibitor Rapamycin on Monocyte-Secreted Chemokines
por: Lin, Hugo You-Hsien, et al.
Publicado: (2014)